1. Home
  2. CCCC vs GPMT Comparison

CCCC vs GPMT Comparison

Compare CCCC & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • GPMT
  • Stock Information
  • Founded
  • CCCC 2015
  • GPMT 2015
  • Country
  • CCCC United States
  • GPMT United States
  • Employees
  • CCCC N/A
  • GPMT N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • GPMT Real Estate Investment Trusts
  • Sector
  • CCCC Health Care
  • GPMT Real Estate
  • Exchange
  • CCCC Nasdaq
  • GPMT Nasdaq
  • Market Cap
  • CCCC 115.0M
  • GPMT 95.4M
  • IPO Year
  • CCCC 2020
  • GPMT 2017
  • Fundamental
  • Price
  • CCCC $1.50
  • GPMT $2.39
  • Analyst Decision
  • CCCC Buy
  • GPMT Buy
  • Analyst Count
  • CCCC 4
  • GPMT 3
  • Target Price
  • CCCC $12.50
  • GPMT $2.38
  • AVG Volume (30 Days)
  • CCCC 1.3M
  • GPMT 473.4K
  • Earning Date
  • CCCC 05-07-2025
  • GPMT 05-06-2025
  • Dividend Yield
  • CCCC N/A
  • GPMT 8.40%
  • EPS Growth
  • CCCC N/A
  • GPMT N/A
  • EPS
  • CCCC N/A
  • GPMT N/A
  • Revenue
  • CCCC $39,783,000.00
  • GPMT N/A
  • Revenue This Year
  • CCCC N/A
  • GPMT N/A
  • Revenue Next Year
  • CCCC $36.31
  • GPMT $25.28
  • P/E Ratio
  • CCCC N/A
  • GPMT N/A
  • Revenue Growth
  • CCCC 98.56
  • GPMT N/A
  • 52 Week Low
  • CCCC $1.09
  • GPMT $1.61
  • 52 Week High
  • CCCC $7.66
  • GPMT $3.86
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 46.32
  • GPMT 62.90
  • Support Level
  • CCCC $1.42
  • GPMT $2.10
  • Resistance Level
  • CCCC $1.64
  • GPMT $2.32
  • Average True Range (ATR)
  • CCCC 0.15
  • GPMT 0.13
  • MACD
  • CCCC 0.02
  • GPMT 0.09
  • Stochastic Oscillator
  • CCCC 25.64
  • GPMT 96.18

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

Share on Social Networks: